Document is current
Any future updates will be listed below
-
Authors
Oishi, Takuya
Luo, Hao-Lun
Hatayama, Yoshiomi
Kawaguchi, Hideo
Sasaki, Daichi
Tanaka, Ryuma
Ishii, Noriaki
Mikami, Jotaro
Okamoto, Teppei
Yamamoto, Hayato
Aoki, Masahiko
Su, Yu-Li
Chen, Yen-Hao
Chang, Yen-Hsiang
Chen, Yen-Ta
Wang, Hung-Jen
Ohyama, Chikara
Hatakeyama, Shingo https://orcid.org/0000-0002-0026-4079
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (19H05556, 20K09517)
- License Information
-
More Information
Article History
Received: 8 November 2024
Accepted: 24 March 2025
First Online: 28 March 2025
Declarations
:
: Shingo Hatakeyama received honoraria from Janssen Pharmaceutical K.K., Astellas Pharma Inc., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Bayer AG, Pfizer Inc., Bristol-Myers Squibb, Merck Biopharma Co., Ltd., Kaneka Corporation, and Nipro Corporation. Other authors have no conflicts of interest to declare. Other authors declare no conflicts of interest.
: All authors approved for the publication.
: Written consent was not obtained in exchange for the public disclosure of study information (opt-out approach).
